| ||
| ||
| Analyst sees promise in Pfizer lung cancer drug BusinessWeek A potential treatment for advanced lung cancer from Pfizer Inc. has about an 80 percent chance of receiving Food and Drug Administration approval this year, according to a Credit Suisse analyst. The world's largest drugmaker presented research earlier ... See all stories on this topic » | ||
| US Cancer Death Rates Decline, But Disparities Persist North Country Public Radio Cancer incidence for women has been falling since 1998. Lung cancer remains the biggest killer for both men and women. All told, about 160000 people in the US are expected to die from it this year. Starting in 1987, more women have died from lung ... See all stories on this topic » | ||
| ||
| Group aims to cut cancer death rates Stuff.co.nz Extra money has been made available for PET scanning, to give a more accurate picture of the stage a cancer is at. Stage one lung cancer has a 70 per cent survival rate but this drops dramatically as the cancer progresses through four stages. ... See all stories on this topic » | ||
| 3 New Medical Tests that Can Save Your Life - But You Have to Ask for Them Forbes (blog) Another silent killer, lung cancer kills more than 160000 people a year in the US and has a shockingly low 16-percent survival rate after five years. The reason? Lung cancer is rarely caught early, when tumors are operable. Known as Early CDT-Lung, ... See all stories on this topic » | ||
|
| ||
| Study: Pfizer lung cancer pill may double survival - Worldnews.com Quick ReadExperimental Pfizer cancer pill may sharply boost survival of lung cancer patients (AP) -- A much-anticipated drug for advanced lung cancer from ... article.wn.com/.../Study_Pfizer_lung_cancer_pill_may_double... |
Tip: Use a plus sign (+) to match a term in your query exactly as is. Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment